Advent Life Sciences and Columbus Venture Partners have led a €22.6m funding round for Spanish immuno-oncology specialist Highlight Therapeutics.
Advent Life Sciences and Columbus Venture Partners have led a €22.6m funding round for Spanish immuno-oncology specialist Highlight Therapeutics.